83802-89-5

Upstream product

• 107-21-1 ethylene glycol 
• 83802-88-4 3-(phenylsulfonyl)cyclohexanone 
• 930-68-7 cyclohexenone 
• 873-55-2 sodium benzenesulfonate 
• 144-55-8 sodium hydrogencarbonate 
• 104-15-4 toluene-4-sulfonic acid 

Downstream Products

• 138832-40-3 7-Benzenesulfonyl-7-(3-methyl-but-2-enyl)-1,4-dioxa-spiro[4.5]decane 
• 138832-44-7 1-(7-Benzenesulfonyl-1,4-dioxa-spiro[4.5]dec-7-yl)-butan-1-ol 
• 138832-41-4 7-Benzenesulfonyl-7-prop-2-ynyl-1,4-dioxa-spiro[4.5]decane 
• 138832-39-0 7-Benzenesulfonyl-7-(2-bromo-allyl)-1,4-dioxa-spiro[4.5]decane 
• 210886-51-4 1,1-(ethylenedioxy)-3-(10-hydroxydecyl)-3-(phenylsulfonyl)-cyclohexane 
• 29179-03-1 (E)-3-(prop-1-en-1-yl)cyclohex-2-en-1-one 
• 138832-48-1 3-(3-Methyl-but-2-enyl)-cyclohex-2-enone 
• 138832-47-0 3-(2-Bromo-allyl)-cyclohex-2-enone 
• 138832-50-5 3-Acryloyl-cyclohex-2-enone 
• 138832-38-9 7-Allyl-7-benzenesulfonyl-1,4-dioxa-spiro[4.5]decane 
• 138832-42-5 (7-Benzenesulfonyl-1,4-dioxa-spiro[4.5]dec-7-yl)-phenyl-methanol 
• 138832-43-6 (7-Benzenesulfonyl-1,4-dioxa-spiro[4.5]dec-7-yl)-(4-methoxy-phenyl)-methanol 
• 138832-45-8 1-(7-Benzenesulfonyl-1,4-dioxa-spiro[4.5]dec-7-yl)-propenone 

Relevant academic research and scientific papers

Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder

The present invention provides preventive and/or therapeutic agents for either one, or both, of a diabetic vascular disorder and a diabetic respiratory disorder comprising, as an active ingredient, a cyclohexenone long chain alcohol compound represented b

THERAPEUTIC AGENT FOR SENSORY ABNORMALITY

The present invention provides therapeutic agents for sensory disorders represented by the following formula (1): [wherein R1, R2, and R3 each represent a hydrogen atom or a methyl group, and X represents a linear or branc

Cyclohexenone long-chain alcohol and medicament containing same

Described is a cyclohexenone long-chain alcohol represented by the formula (1): wherein R1, R2 and R3 each independently represents a hydrogen atom or a methyl group and X represents a C10-18 alkylene or alkenylene group. The cyclohexanone long-chain alco

Cyclohexenonic long-chain fatty alcohols as neuronal growth stimulators

Neurotrophic factors play an important role in the development and maintenance of neurons, thus providing a suitable therapeutic approach for the treatment of neurodegenerative diseases. However, their clinical use has revealed problematic because of a number of technical and biological disadvantages. Among the different strategies proposed to overcome such difficulties, the search for non-peptide substances with neurotrophic potential is giving promising results. Here we will expose major findings in this field, drawing special attention to cyclohexenonic long-chain fatty alcohols, a novel family of compounds that promote neuronal survival and neurite outgrowth.

Effect of cyclohexenonic long chain fatty alcohols on neurite outgrowth. Study on structure-activity relationship

Four series of long chain fatty alcohols bearing a cyclohexenone moiety in addition to a ω-alkanol side chain were synthesized using 'Umpolung' reactivity strategy. Their effect on neurite outgrowth was evaluated by means of fetal rat neurons in culture. The length of the ω-hydroxy side chain is a crucial factor for biological activity.